Hostname: page-component-7b7567c8c-p67k6 Total loading time: 0 Render date: 2026-11-19T18:57:14.745Z Has data issue: false hasContentIssue false

Bromocriptine-associated ototoxicity*

Published online by Cambridge University Press:  29 June 2007

Philippe L. Lanthier
Affiliation:
Research Fellow.
Marsha Y. Morgan*
Affiliation:
Honorary Senior Lecturer in Medicine; William Gibson Scholar of the Royal Society of Medicine.
John Ballantyne
Affiliation:
Consulting ENT Surgeon.
*
Academic Department of Medicine, Royal Free Hospital School of Medicine, Rowland Hill Street, Hampstead, London NW3 4PF.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Three patients treated with bromocriptine for chronic hepatic encephalopathy showed audiometric evidence of bilateral sensori-neural hearing-loss. Audiometrically, the hearing improved in all three patients when the bromocriptine dosage was reduced, thus suggesting that this drug may produce a reversible ototoxicity.

Information

Type
Clinical records
Copyright
Copyright © JLO (1984) Limited 1984